OCC 2.34% 65.5¢ orthocell limited

Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-76

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 14,833 Posts.
    lightbulb Created with Sketch. 286
    O' Beirn is orthopaedic surgeon with an interest in nerve repair. He's not a neurosurgeon or a neurologist. The report refers to him as a orthopaedic nerve specialist. Who wrote this report? The data is impossible to interpret because everything is clumped together. Pathetic. Deserves a sell off.
    Last edited by float^: 09/10/19
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
65.5¢
Change
0.015(2.34%)
Mkt cap ! $156.6M
Open High Low Value Volume
64.5¢ 69.0¢ 64.0¢ $707.4K 1.056M

Buyers (Bids)

No. Vol. Price($)
1 169 65.5¢
 

Sellers (Offers)

Price($) Vol. No.
68.0¢ 15538 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.